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Advances in knowledge 
• In the MESA cohort, greater trabeculation of the left ventricle is associated with 
worse myocardial strain (B=4.0% per unit fractal dimension increase in 
trabeculation; p<0.0001).   
• In the MESA cohort, greater left ventricular trabeculation is not associated with 
myocardial fibrosis as measured by native and post contrast T1 mapping cardiac MR.    
 
Implications for patient care 
• 21% (230/1123) of MESA participants have excess trabeculation of the left ventricle 
exceeding the current diagnostic threshold for left ventricular non compaction 
disease using fractal analysis with a cut-off of FD ≥1.3.    
• Excess greater LV trabeculation is associated with decreased average regional 




Average regional myocardial function is worse in individuals with greater LV 
trabeculation.  
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Purpose:  To determine if excess greater LV trabeculation is associated with decreased 
average regional myocardial function and/or diffuse fibrosis.    
Methods: This was a HIPPA-compliant institutional board approved multicenter study; all 
participants provided written informed consent. Study participants of the Multi-Ethnic 
Study of Atherosclerosis (MESA) underwent a comprehensive cardiac magnetic resonance 
(cardiac MR) exam. Trabeculation of the LV was measured by the maximal apical fractal 
dimension (FD) a novel marker of endocardial complexity. Demographic covariates, 
cardiovascular risk factors and cardiac MR measures were compared across quartiles of FD.  
Associations between FD and peak regional systolic circumferential strain (Ecc) and T1-
time, a surrogate for diffuse myocardial fibrosis, were assessed in multivariable linear 
regression models.  
Results:  1123 subjects (53% female, mean age±SD: 67±9 years) had FD and Ecc 
measurements and 992 subjects had T1 and Ecc measurements.  The mean FD was 
1.2±0.07; the mean Ecc was -18.3±2.27.  Global volumes and ejection fraction showed no 
differences between quartiles of FD. However, with increasing FD–quartile, Ecc was greater 
(indicating worse average regional function) (p<0.0001).  After adjustment, greater 
trabeculation was associated with 21% worse myocardial strain (relative to the mean) per 
unit change FD (B=4.0%; p=0.0001).  There was no association between the degree of 
trabeculation and diffuse fibrosis measured by T1 mapping. 
Conclusion: Average regional LV function was worse in individuals with greater LV 
trabeculation, supporting the concept of hypertrabeculation being an epiphenomenon of 
disease.  
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The trabeculae carneae are a network of slim columns of myocardial cells covered 
by endocardial cells at the luminal surface of the left and right ventricle. During embryonic 
cardiac development, trabeculae form by invagination of cardiomyocytes into the lumen (1). 
Trabeculated myocardium functions to increase cardiac output and enable oxygen supply 
prior to coronary vascularization.  As the myocardium develops, trabeculae compact leading 
to an increase in thickness of the compact myocardium, that represents the major part of 
myocardial mass of the mature heart. Simultaneously coronary vessels develop (1).  
Abnormal trabecular compaction is a diagnostic imaging feature of left ventricular 
noncompaction cardiomyopathy (LVNC), a rare primary genetic cardiomyopathy 
characterized by excess myocardial trabeculation more than twice as thick as the 
underlying myocardial wall (2).  LVNC is associated with heart failure, regional wall motion 
abnormalities and myocardial fibrosis (3-11).  However, individuals without overt 
cardiovascular disease and normal cardiac function frequently show excess trabeculation; 
over 30% of normal individuals have a ratio of noncompacted to compacted myocardium 
greater than 2.3 (12).  In such individuals, the clinical significance of excess trabeculation as 
a sign of current or future disease expression is not currently understood.  Mechanistically, 
it would seem likely that regions of hypertrabeculated myocardium may have lower 
contractility compared to normal myocardium.  However the relationship of 
hypertrabeculated myocardium to contractile function and fibrosis in individuals without 
LNVC disease is currently unknown.  
The ratio of the thickness of noncompacted (NC) versus compacted (C) myocardium 
(NC/C) is a simple and fast method to quantify trabeculation that is currently most widely 
used (13).  A more comprehensive measure of LV trabeculation can be performed by fractal 
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analysis (14).  The fractal dimension is a unitless index to assess endocardial complexity (14, 
15). The maximal FD in the apical half of the LV (FD) is higher in patients diagnosed with 
LVNC compared to healthy volunteers (14). Compared to the calculation of the NC/C ratio, 
the fractal method has been demonstrated to be more accurate and reproducible (14). 
Although the importance of detecting excess trabeculation is reasonably well 
understood in overt LVNC disease, the significance of this common finding is not 
understood in individuals who do not have overt clinical cardiomyopathy.   We 
hypothesized that myocardial strain is impaired in subjects with greater trabeculation and 
may be associated with diffuse fibrosis. Therefore, the purpose of our study was to 
determine if excess greater LV trabeculation is associated with decreased average regional 
myocardial function and/or diffuse fibrosis.    
 
Materials and Methods 
Study participants 
 This study was approved by the institutional review boards of each of the 
participating field sites in the United States, and all participants provided written informed 
consent. All sites were Health Insurance Portability and Accountability Act-compatible.  
The Multi-Ethnic Study of Atherosclerosis (MESA) is an ongoing population-based 
longitudinal study initiated in July 2000. At enrollment, study participants were free of 
clinically recognized cardiovascular disease (16).  Ten years after baseline examination, 
3015 subjects had an additional cardiac MR exam and a subset of those had regional 
function assessment (using MRI tagging), late gadolinium enhancement (LGE) imaging and 
T1-mapping. Participants with a focal myocardial scar on LGE imaging were excluded since 
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focal LGE is associated with regional myocardial dysfunction, which would otherwise 
confound the analysis.  In addition, participants with inadequate MR image quality 
hampering analysis and missing data were also excluded (Figure 1).  
In a previous publication (17) the range of fractal dimension and its determinants 
were described for 2547 subjects of the MESA population. The current study focusses on the 
analysis of the relationship between the fractal dimension and average regional myocardial 
function and diffuse myocardial fibrosis, respectively in a subset of these participants.   
Cardiovascular MR 
Cardiac MR exams were performed at the six MESA field centers on 1.5 Tesla MR 
scanners as previously described (18, 19).  In brief, electrocardiogram (ECG) gated long and 
short axis  (SAX) cine images were acquired using a steady-state free precession (SSFP) 
sequence with temporal resolution ≤40msec, 8mm slice thickness, 2mm gap, repetition time 
(TR)/echo time (TE) 2.2/1.1msec, 45-70° flip angle. Tagged images were obtained with a 
segmented k-space, ECG gated fast low angle shot pulse sequence acquired in three SAX 
slices with two orthogonally oriented parallel striped tags using spatial modulation of 
magnetization with a field of view (FOV) of 360x360mm, flip angle 10°, TE 2.5ms, matrix 
size 256x128, slice thickness 10mm, 9 phase encoding views per segment, spatial resolution 
1.4x2.8x10mm3, temporal resolution 25ms, tag spacing 7mm. Participants without 
contraindications underwent late contrast enhancement (LGE) images 15min after an 
intravenous bolus injection of gadopentetate dimeglumine (0.15mmol/kg [Magnevist, Bayer 
Healthcare Pharmaceuticals, Montville, New Jersey]) to identify myocardial scar.  As 
described previously (19), T1-mapping sequences included pre-contrast and delayed 
images 12 and 25 minutes after contrast injection using a modified Look-Locker (MOLLI) 
sequence consisting of 11 source images in 17 heartbeats with flip angle 35°; TR/TE 
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2.2/1.1ms; FOV 360×360mm; matrix 192×183; slice thickness 8mm; generalized 
autocalibrating partially parallel acquisitions factor 2. 
Image evaluation  
 LV volumes and function were measured using CIM software version 6.2 (Auckland, 
New Zealand) (20). FD was measured on SAX cine SSFP images (figure 2) (by G.C. with 6 
years of experience in cardiac MR imaging) as described previously (17). In brief, afer image 
segmentation to identify the endocardial border, the FD of the endocardial border was 
calculated using a box counting method. Maximal apical FD (FD) was the maximum value 
derived from the apical half of the LV stack. Thickness of the compact and noncompact 
(trabeculated) LV myocardium were measured at end-diastole on long axis SSFP images in 
the middle of 8 LV regions (by F.Z. and N.K.B. with 6 and 8 years of experience in cardiac MR 
imaging, respectively) (12). Maximal NC/C  (NC/C) was calculated as the maximum value of 
the 8 segments in cases where measurements were performed for all 8 segments. 
 T1-mapping data was evaluated using MASS research software (MASS V2010-EXP; 
Leiden University Medical Center, Leiden, The Netherlands) (by C.Y.L. and B.A.V. with 13 
and 12 years of experience in cardiac MR imaging, respectively). The extracellular volume 
(ECV) was calculated as ΔR1myocardium/ΔR1blood*(1-hematocrit),  
where ΔR1myocardium=1/T1myocardium pre contrast- 1/T1myocardium post contrast  
and ΔR1blood=1/T1blood pre contrast-1/T1blood post contrast (21). 
Tagged short axis slices were analyzed using Harmonic Phase software (Diagnosoft, 
Palo Altro, CA) (22). Peak regional systolic circumferential strain (Ecc) was calculated for 12 
segments: anterior, inferior, septal, and lateral at basal, midcavity and apical level (23). 
Mean peak Ecc was calculated as the mean of the 12 segments in cases where 
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measurements were performed for all 12 segments. Ecc is a negative value; lower (more 
negative) values indicate greater circumferential strain and thus better regional function.  
Statistical analysis 
 Demographic indices, cardiovascular risk factors and cardiac MR measures of 
volume and function were evaluated for the entire cohort and were compared across 
quartiles of FD using one-way analysis of variance (ANOVA) for continuous covariates and 
chi-square test for categorical covariates. Continuous variables are presented as mean±SD 
and categorical variables as frequencies and percentages.  
The missing data approach was complete-case analysis, which uses only 
participants who have all variables observed. To avoid bias when calculating the mean Ecc 
only those cases where measuring Ecc was feasible for all 12 segments were included.  
The associations between the independent variable FD and the dependent variables 
Ecc, T1-time and ECV, respectively were assessed by linear regression in univariate and 
multivariable models per subject. Additionally, regression analysis was performed with 
NC/C instead of FD as independent variable. Normality of dependent variables was assessed 
by Shapiro-Wilk test. Multivariable models were adjusted for demographic covariates 
(model 1) including age, gender, ethnicity, height and weight, additionally for traditional 
cardiovascular risk factors (model 2: systolic blood pressure, hypertension, smoking, 
diabetes mellitus, high density lipoprotein, lipid-lowering medication and total cholesterol) 
and for cardiac MR measures (model 3: LV end-diastolic volume [LVEDV] and LV ejection 
fraction [LVEF]). Models including pre-contrast T1-time were additionally adjusted for 
heart rate.  
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Probability values <0.05 were considered statistically significant. Statistical analysis 





Table 1 indicates the population demographic characteristics, traditional 
cardiovascular risk factors and mean and standard deviation of the cardiac MR variables for 
subjects included in the analysis of the relationship between trabeculation and strain and 
T1-time, respectively. There were no clinically relevant differences in demographics 
between the subsets of subjects included in the analysis and the 1840 subjects of the MESA 
5 cohort with a cardiac MR exam including LGE imaging. The mean of FD was 1.2±0.07. The 
mean of NC/C was 2.1±0.68. The mean Ecc was -18.3±2.27. Mean T1-times were 
974.7±42.1ms pre-contrast, 455.3±40.0 at 12 minutes and 518.8±40.2 at 25 minutes after 
contrast administration. Mean ECV was 0.27±0.3.   
230/1123 (21%) subjects had a FD of ≥1.3, considered the threshold for LVNC using 
fractal analysis (14). For comparison, 33% (247/745) of subjects had a NC/C >2.3, which is 
considered the cut-off for LVNC in cardiac MR imaging (13). 
Table 2 shows demographic characteristics, traditional risk factors and cardiac MR 
measures stratified by FD. Participants with a higher FD were more likely to be male and of 
Black or Hispanic ethnicity while the proportion of Chinese was higher in the lower 
quartiles. Subjects in the quartiles with higher FD were taller, had a higher body weight, 
were more likely to have diabetes, had on average a higher systolic blood pressure and 
were more likely to be smokers. Mean HDL cholesterol tended to be lower in higher FD -
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Quartiles while total cholesterol was lower. There were no statistically significant 
differences in LVEDV and LVEF between quartiles of FD. Circumferential strain tended to be 
more positive (indicating worse regional function) with increasing FD –quartile (figure 3).  
Relationship between trabeculation and circumferential strain  
In univariate analysis, a higher maximal apical FD was associated with more positive 
peak global circumferential strain (indicating worse average regional function) (regression 
coefficient [B]=6.6%; p<0.0001). The association persisted after adjustment for 
demographic covariates (B=4.0%; p<0.0001), traditional cardiovascular risk factors 
(B=3.6%; p<0.0001) and after adjustment for cardiac MR measures of left ventricular 
volume and function (B=2.8%; p=0.002) (table 3). In the fully adjusted model, in addition to 
FD ,  age, male gender, weight, diabetes mellitus and systolic blood pressure were also 
associated with more positive (worse) circumferential strain (table 4).  
In an analysis parallel to that performed above for  FD, in 745 individuals with 
complete data, there was no relationship between the conventional measure of 
trabeculation (NC/ C) in the fully adjusted model (p =0.073).   
Relationship between fractal dimension and T1-time and ECV, respectively  
In univariate analysis and multivariable models (n=992) maximal apical FD was not 
associated with pre-contrast T1-time nor with T1 time at 12 minutes and 25 minutes after 
contrast administration.  There was no association of FD with ECV persisting in 
multivariable analysis.   
NC/C  was not associated with pre-contrast or post-contrast T1 times (n=650) nor 
ECV (n=372) (p>0.05 for all). 
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SSFP cine cardiac MR images readily demonstrate variations in the degree of 
trabeculation of the left ventricle.  In genetic LVNC disease, the degree of trabeculation 
seems to be related to disease severity. Using fractal analysis, this study shows that average 
regional myocardial function is worse in individuals with greater LV trabeculation. 
Interestingly, greater trabeculation was not associated with diffuse myocardial fibrosis as 
measured by alteration in T1 time.  These results suggest a mechanical “link” between LV 
trabeculation and the effectiveness of myocardial function.  
Relationship between left ventricular trabeculation and average regional myocardial function  
The present study supports the hypothesis that LV function is at least in part 
dependent on the degree of trabeculated myocardium.   In the MESA cohort, subjects with 
highly trabeculated LV myocardium had worse average regional function.  This relationship 
was found even after adjustment for demographic and clinical factors as well as global LV 
function. Of interest, greater NC/C ratio was unable to detect these relationships.  This 
supports accumulating evidence that, although NC/C ratio is easy to measure in the clinic, it 
is not specific (33% [247/745]of subjects in the MESA cohort with NC/C ratio >2.3).  In 
addition, NC/C ratio is a 1-dimensional measurement at a single point in the left ventricle 
which does not comprehensively describe myocardial trabeculation.  Fractal dimension 
reflects myocardial complexity in a region of myocardium, in a fashion similar to the 
concept of average regional myocardial strain.   
In a previous publication, Zemrak et al. (24) found that subjects with abnormal 
NC/C ratio had no deterioration of ejection fraction over the prior 10 years.  However, it is 
well known that ejection fraction can be normal while myocardial strain is impaired (e.g., as 
in the case of heart failure with preserved ejection fraction).  It remains unknown if subject 
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with hypertrabeculation and impaired strain will subsequently develop deterioration of 
global function and clinical symptoms or if myocardial dysfunction will remain stable and 
subclinical.  
In this cohort, the average FD in the myocardial apex was 1.2.  Captur et al. 
previously reported patients with LVNC disease have a FD greater than 1.3 (14) indicating 
small changes in FD may be clinically meaningful.  Similarly, myocardial strain is a sensitive 
measure of LV function and strain is highly conserved in normal individuals (25).  In the 
current study, the mean circumferential strain was -18.3%.  In our unadjusted analysis, a 
0.1 unit increase in FD was associated with an absolute increase of +0.6% strain, or 
approximately 3% of the mean value.  Our sample size was sufficient to account for 14 
additional variables that might affect regional function in multivariable models.  Even in 
fully adjusted models, the association of greater trabeculation with worse average regional 
function remained statistically significant.  Not surprisingly, less sensitive measures of 
trabeculation and function (NC/C ratio and ejection fraction, respectively), did not reveal 
these associations. 
Relationship between left ventricular trabeculation and measures of diffuse myocardial 
fibrosis 
 In previous publications focal myocardial fibrosis has been described as a feature of 
LVNC (4, 5, 8, 10). Besides these reports of focal fibrosis/scars in LVNC, in a study by Jenni 
et al histopathology revealed also interstitial fibrosis as a finding in 6 of 7 hearts diagnosed 
with LVNC (26).  In a study recently published by Zhou et al, subjects with a diagnosis of 
LVNC had a significantly longer native T1-time (used as surrogate of diffuse myocardial 
fibrosis) compared to healthy volunteers independent of the presence of LGE (27). 
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In this context our aim was to investigate the relationship between extent of 
trabeculation and diffuse myocardial fibrosis using T1-time and ECV, respectively measured 
by cardiac MR as surrogate.  However, in our subset of study participants without known 
cardiovascular disease at enrollment there was no association between trabeculation and 
native or post contrast T1-time or ECV.  
Participants in our population-based study had a broad spectrum of trabeculation.  
The FD in the highest quartile was between 1.24 and 1.45.  Twenty one percent (21%, 
230/1123) of our subjects had a FD ≥1.3, previously defined as the threshold for LVNC and 
33% [247/745] of subjects in this study had a NC/C ratio >2.3, still widely used as cut-off 
for LVNC in cardiac MR imaging. This discrepancy is explained by a lack of diagnostic 
criteria for a LVNC with a high specificity. The current criteria focus on thickness or amount 
of trabeculation.  Given the overlap with normal population and the results of this study, 
improved LVNC criteria may incorporate some measurement of  systolic function (28) 
and/or morphologic criteria such as the presence of a layer of tissue between the 
noncompacted myocardium and the ventricular cavity (29).  The current study shows once 
more that revision of the current criteria is required to distinguish between LVNC disease 
as a genetic disorder and morphologically hypertrabeculated LV.  
A limitation of this study is the cross-sectional design, which precludes a causal 
interpretation of the results. It remains unclear if hypertrabeculation leads to a 
deterioration of average regional function or if increased trabeculation might be an 
adaptive process resulting from an impaired function. The latter would be of biological 
interest as it would suggest that LV trabecular patterning imprinted at birth, is modulated 
throughout life as a consequence of cardiac loading and other haemodynamic conditions.  
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The present data indicates that hypertrabeculation might be a epiphenomenon of disease 
associated with an impaired average regional function.   
 
  
Page 14 of 25































































1. Samsa LA, Yang B, Liu J. Embryonic cardiac chamber maturation: Trabeculation, 
conduction, and cardiomyocyte proliferation. Am J Med Genet C Semin Med Genet. 
2013;163C(3):157-68. 
2. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of 
the cardiomyopathies: an American Heart Association Scientific Statement from the Council 
on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and 
Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary 
Working Groups; and Council on Epidemiology and Prevention. Circulation. 
2006;113(14):1807-16. 
3. Bellavia D, Michelena HI, Martinez M, et al. Speckle myocardial imaging modalities 
for early detection of myocardial impairment in isolated left ventricular non-compaction. 
Heart. 2010;96(6):440-7. 
4. Burke A, Mont E, Kutys R, Virmani R. Left ventricular noncompaction: a pathological 
study of 14 cases. Hum Pathol. 2005;36(4):403-11. 
5. Dursun M, Agayev A, Nisli K, et al. MR imaging features of ventricular 
noncompaction: emphasis on distribution and pattern of fibrosis. Eur J Radiol. 
2010;74(1):147-51. 
6. Kalapos A, Domsik P, Forster T, Nemes A. Left ventricular strain reduction is not 
confined to the noncompacted segments in noncompaction cardiomyopathy-insights from 
the three-dimensional speckle tracking echocardiographic MAGYAR-path study. 
Echocardiography. 2014;31(5):638-43. 
7. Niemann M, Liu D, Hu K, et al. Echocardiographic quantification of regional 
deformation helps to distinguish isolated left ventricular non-compaction from dilated 
cardiomyopathy. Eur J Heart Fail. 2012;14(2):155-61. 
8. Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M. Myocardial fibrosis in 
isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail. 
2011;13(2):170-6. 
9. Pacileo G, Baldini L, Limongelli G, et al. Prolonged left ventricular twist in 
cardiomyopathies: a potential link between systolic and diastolic dysfunction. Eur J 
Echocardiogr. 2011;12(11):841-9. 
10. Wan J, Zhao S, Cheng H, et al. Varied distributions of late gadolinium enhancement 
found among patients meeting cardiovascular magnetic resonance criteria for isolated left 
ventricular non-compaction. J Cardiovasc Magn Reson. 2013;15:20. 
11. Wang C, Deng YB, Zhu Y, Liu YN, Bi XJ. Evaluation of subtle myocardial 
noncompaction by contrast echocardiography in patients with hypertrophic 
cardiomyopathy and its relationship with regional ventricular systolic dysfunction. J 
Ultrasound Med. 2012;31(10):1551-7. 
12. Kawel N, Nacif M, Arai AE, et al. Trabeculated (noncompacted) and compact 
myocardium in adults: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 
2012;5(3):357-66. 
13. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left Ventricular Non-Compaction. 
Journal of the American College of Cardiology. 2005;46(1):101-5. 
14. Captur G, Muthurangu V, Cook C, et al. Quantification of left ventricular trabeculae 
using fractal analysis. J Cardiovasc Magn Reson. 2013;15:36. 
15. Captur G, Karperien AL, Li C, et al. Fractal frontiers in cardiovascular magnetic 
resonance: towards clinical implementation. J Cardiovasc Magn Reson. 2015;17(1):80. 
16. Bild DE, Bluemke DA, Burke GL, et al. Multi-ethnic study of atherosclerosis: 
objectives and design. Am J Epidemiol. 2002;156(9):871-81. 
Page 15 of 25






























































17. Captur G, Zemrak F, Muthurangu V, et al. Fractal Analysis of Myocardial 
Trabeculations in 2547 Study Participants: Multi-Ethnic Study of Atherosclerosis. Radiology. 
2015:142948. 
18. Donekal S, Venkatesh BA, Liu YC, et al. Interstitial fibrosis, left ventricular 
remodeling, and myocardial mechanical behavior in a population-based multiethnic cohort: 
the Multi-Ethnic Study of Atherosclerosis (MESA) study. Circ Cardiovasc Imaging. 
2014;7(2):292-302. 
19. Liu CY, Liu YC, Wu C, et al. Evaluation of age-related interstitial myocardial fibrosis 
with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study 
of Atherosclerosis). J Am Coll Cardiol. 2013;62(14):1280-7. 
20. Young AA, Cowan BR, Thrupp SF, Hedley WJ, Dell'Italia LJ. Left ventricular mass and 
volume: fast calculation with guide-point modeling on MR images. Radiology. 
2000;216(2):597-602. 
21. Arheden H, Saeed M, Higgins CB, et al. Reperfused rat myocardium subjected to 
various durations of ischemia: estimation of the distribution volume of contrast material 
with echo-planar MR imaging. Radiology. 2000;215(2):520-8. 
22. Garot J, Bluemke DA, Osman NF, et al. Fast determination of regional myocardial 
strain fields from tagged cardiac images using harmonic phase MRI. Circulation. 
2000;101(9):981-8. 
23. Donekal S, Ambale-Venkatesh B, Berkowitz S, et al. Inter-study reproducibility of 
cardiovascular magnetic resonance tagging. J Cardiovasc Magn Reson. 2013;15:37. 
24. Zemrak F, Ahlman MA, Captur G, et al. The relationship of left ventricular 
trabeculation to ventricular function and structure over a 9.5-year follow-up: the MESA 
study. J Am Coll Cardiol. 2014;64(19):1971-80. 
25. Moore CC, Lugo-Olivieri CH, McVeigh ER, Zerhouni EA. Three-dimensional systolic 
strain patterns in the normal human left ventricle: characterization with tagged MR imaging. 
Radiology. 2000;214(2):453-66. 
26. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic 
and pathoanatomical characteristics of isolated left ventricular non-compaction: a step 
towards classification as a distinct cardiomyopathy. Heart. 2001;86(6):666-71. 
27. Zhou H, Lin X, Fang L, et al. Characterization of Compacted Myocardial 
Abnormalities by Cardiac Magnetic Resonance With Native T1 Mapping in Left Ventricular 
Non-Compaction Patients- A Comparison With Late Gadolinium Enhancement. Circ J. 
2016;80(5):1210-6. 
28. Captur G, Syrris P, Obianyo C, Limongelli G, Moon JC. Formation and Malformation of 
Cardiac Trabeculae: Biological Basis, Clinical Significance, and Special Yield of Magnetic 
Resonance Imaging in Assessment. Can J Cardiol. 2015;31(11):1325-37. 
29. Freedom RM, Yoo SJ, Perrin D, Taylor G, Petersen S, Anderson RH. The 
morphological spectrum of ventricular noncompaction. Cardiol Young. 2005;15(4):345-64. 
 
Page 16 of 25



































































Subjects with complete 
FD and Ecc 
measurements 
n=1123  
Subjects with complete 
FD and T1 
measurements 
n=992  
Female 593 (52.8) 521 (52.5) 




Ethnicity   
   White 515 (45.9) 519 (52.3) 
   Chinese 124 (11.0) 114 (11.5) 
   African American 251 (22.4) 220 (22.2) 
   Hispanic 233 (20.7) 139 (14.0) 
Height, cm 166.1±9.7 166.7±9.8 
Weight, kg 77.4±16.5 78.6±17.3 
HDL cholesterol, mg/dL 55.5±16.2 55.2±16.3 
Total cholesterol, mg/dL 184.6±35.8 183.3±36.3 
Lipid medication use 396 (35.3) 364 (36.7) 
Diabetes mellitus 178 (15.9) 150 (15.1) 
Systolic blood pressure, mmHg 121.8±19.4 121.1±18.7 
Hypertension medication use 526 (46.8) 476 (48.0) 
Smokers 573 (51.0) 526 (53.0) 
LVEDV, ml 124.0±30.1 123.6±30.6 
LVEF, % 62.2±6.5 62.4±6.6 
Mean Ecc, % -18.3±2.27 NA 
FD 1.2±0.07 1.2±0.07 
T1 pre, ms NA 974.7±42.1 
T1 12min, ms NA 455.3±40.0 
T1 25min, ms NA 518.8±40.2 
ECV NA 0.27±0.3* 
Characteristics of subjects available per analysis.  Values are mean ± SD or n (%).  
HDL, high-density lipoprotein; Lipid medication, lipid-lowering medication; LVEDV, left ventricular end-diastolic volume; 
LVEF, left ventricular ejection fraction; Ecc, peak regional systolic circumferential strain; FD, fractal dimension; T1 pre, 
myocardial T1 time prior to contrast administration; T1 12min, myocardial T1 time 12min after contrast administration; T1 
25min, myocardial T1 time 25min after contrast administration; ECV, extracellular volume; *n=544  
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Q1 vs Q4 
Female 170 (60.7) 163 (58.0) 148 (52.7) 112 (39.9) <0.0001 <0.0001 
Age, years  67.4±8.5 65.8±8.4 66.9±8.7 68.4±9.0 0.003 0.170 
Ethnicity       
   White 137 (48.9) 128 (45.6) 131 (46.6) 119 (42.3) 0.469 0.118 
   Chinese 46 (16.4) 39 (13.9) 26 (9.3) 13 (4.6) <0.0001 <0.0001 
   African American 54 (19.3) 57 (20.3) 65 (23.1) 75 (26.7) 0.148 0.037 
   Hispanic 43 (15.4) 57 (20.3) 59 (21.0) 74 (26.3) 0.016 0.001 
Height, cm 164.7±9.6 165.4±9.6 166.7±10.1 167.5±9.4 0.002 <0.0001 
Weight, kg 73.4±16.9 74.6±14.1 78.8±17.1 82.6±16.3 <0.0001 <0.0001 
HDL cholesterol, mg/dL 57.3±17.1 56.7±16.5 55.4±15.8 52.7±14.9 0.004 0.001 
Total cholesterol, 
mg/dL 
186.8±38.2 185.4±34.1 185.6±34.6 180.5±36.1 0.162 0.045 
Lipid medication 92 (32.9) 96 (34.2) 92 (32.7) 116 (41.3) 0.107 0.039 
Diabetes mellitus 40 (14.3) 30 (10.7) 43 (15.3) 65 (23.1) 0.001 0.007 
SBP, mmHg 120.0±18.0 120.0±19.5 122.1±18.8 125.3±20.9 0.003 0.001 
Hypertension 
medication 
117 (41.8) 125 (44.5) 121 (43.1) 163 (58.0) <0.0001 <0.0001 
Smokers 135 (48.2) 137 (48.8) 140 (49.8) 161 (57.3) 0.109 0.031 
LVEDV, ml 121.3±28.4 123.3±26.9 126.4±31.1 125.0±33.4 0.216 0.164 
LVEF, % 62.4±5.9 62.5±6.2 62.2±6.8 61.8±7.1 0.523 0.244 
Ecc, % -18.7±2.1 -18.6±2.1 -18.3±2.4 -17.5±2.3 <0.0001 <0.0001 
*1123 with complete data.  Values are mean ± SD or n (%).  
FD, fractal dimension; HDL, high-density lipoprotein; Lipid medication, lipid-lowering medication; SBP, systolic blood 
pressure; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; Ecc, peak regional systolic 
circumferential strain; Q1-Q4 quartile 1-4 
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Table 3. Relationship of maximal apical fractal dimension to mean peak regional systolic circumferential 
strain.   
Analysis B p 
Univariate 6.556 <0.0001 
Multivariable Model 1 4.045 <0.0001 
Multivariable Model 2 3.623 <0.001 
Multivariable Model 3* 2.838 0.002 
 
Dependent variable, peak regional systolic circumferential strain (Ecc); B, unstandardized regression coefficient, absolute 
difference in Ecc (%) related to a change of one unit of maximal apical fractal dimension; Model 1 adjusted for age, gender, 
ethnicity, height and weight; Model 2 additionally adjusted for systolic blood pressure, hypertension, smoking, diabetes 
mellitus, high density lipoprotein, lipid-lowering medication and total cholesterol; Model 3 additionally adjusted for LV end-
diastolic volume and LV ejection fraction; *, for detailed analysis of the relationship between all covariates and 
circumferential strain see table 4 
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Table 4. Relationship of maximal apical fractal dimension and covariates to peak regional systolic 
circumferential strain in the fully adjusted multi-variable model * 
Variable B β p 
FD 2.838 0.088 0.002 
Age 0.017 0.064 0.037 
Male gender 0.874 0.192 <0.0001 
Chinese ethnicity -0.312 -0.043 0.179 
African American ethnicity 0.015 0.003 0.924 
Hispanic ethnicity -0.435 -0.078 0.014 
Height 0.011 0.045 0.342 
Weight 0.036 0.263 <0.0001 
HDL cholesterol 0.005 0.035 0.265 
Total cholesterol 0.001 0.020 0.534 
Lipid medication 0.205 0.043 0.143 
Diabetes mellitus 0.424 0.068 0.018 
SBP 0.015 0.125 <0.0001 
Hypertension medication -0.020 -0.004 0.881 
Smokers 0.152 0.034 0.230 
LVEDV -0.024 -0.324 <0.0001 
LVEF -0.067 -0.193 <0.0001 
*Dependent variable, peak regional systolic circumferential strain (Ecc); B, unstandardized regression coefficient; absolute 
difference in Ecc (%) related to a change of one unit of the independent variables; β, standardized coefficient; FD, fractal 
dimension; HDL, high-density lipoprotein; Lipid medication, lipid-lowering medication; SBP, systolic blood pressure; LVEDV, 
left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction
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Figure 1. Participant enrollment   
Cardiac MR, cardiac magnetic resonance; w/o, without; LGE, late gadolinium enhancement; 
FD, fractal dimension 
 
Figure 2.  Analysis of fractal dimension 
Measuring the fractal dimension by fractal analysis of short axis cine steady-state free 
precession images in four exemplar subjects from this MESA cohort: one subject with low 
fractal dimension (top row) and three subjects with high fractal dimension (row 2, 3 and 4). 
Colored lines show contouring of endocardial borders. The fractal dimension indicates how 
extensively the contour fills two-dimensional space. The image on the left shows planning of 
the short axis cine stack. Numbers on top of each short axis image indicate the fractal 
dimension of the respective slice. The colored panels on the right provide characteristics of 
the four subjects. 
FD, fractal dimension; AfrcAm, African American; Hisp; Hispanic; BMI, body mass index; HT 
med, hypertension medication; Y, yes; N, no; SBP, systolic blood pressure  
 
Figure 3. Circumferential strain by quartiles of FD 
Ecc, peak regional systolic circumferential strain; FD, fractal dimension; Quartile 1, 1.01-
1.15; Quartile 2, 1.15-1.12; Quartile 3, 1.12-1.24; Quartile 4, 1.24-1.4; Error bars indicating 
95% confidence interval 
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Figure 1. Cardiac MR, cardiac magnetic resonance; w/o, without; LGE, late gadolinium enhancement; FD, 
fractal dimension.  
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Figure 2. Analysis of fractal dimension. Measuring the fractal dimension by fractal analysis of short axis cine 
steady-state free precession images in four exemplar subjects from this MESA cohort: one subject with low 
fractal dimension (top row) and three subjects with high fractal dimension (row 2, 3 and 4). Colored lines 
show contouring of endocardial borders. The fractal dimension indicates how extensively the contour fills 
two-dimensional space. The image on the left shows planning of the short axis cine stack. Numbers on top 
of each short axis image indicate the fractal dimension of the respective slice. The colored panels on the 
right provide characteristics of the four subjects. FD, fractal dimension; AfrcAm, African American; Hisp; 
Hispanic; BMI, body mass index; HT med, hypertension medication; Y, yes; N, no; SBP, systolic blood 
pressure.  
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Figure 3. Circumferential strain by quartiles of FD. Ecc, peak regional systolic circumferential strain; FD, 
fractal dimension; Quartile 1, 1.01-1.15; Quartile 2, 1.15-1.12; Quartile 3, 1.12-1.24; Quartile 4, 1.24-1.4; 
Error bars indicating 95% confidence interval.  
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